U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C13H17N3.C4H4O4
Molecular Weight 331.3663
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BRL-44408 MALEATE

SMILES

OC(=O)\C=C/C(O)=O.CC1N(CC2=NCCN2)CC3=CC=CC=C13

InChI

InChIKey=DDIQGSUEJOOQQQ-BTJKTKAUSA-N
InChI=1S/C13H17N3.C4H4O4/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13;5-3(6)1-2-4(7)8/h2-5,10H,6-9H2,1H3,(H,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1-

HIDE SMILES / InChI

Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula C13H17N3
Molecular Weight 215.2942
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

BRL-44408, a potent (Ki=8.5 nM) and selective (>50-fold) α2A-adrenoceptor antagonist (KB=7.9 nM). BRL-44408 revealed antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism. Preclinical characterization of the neurochemical and behavioural profile of BRL-44408 suggests that selective antagonism of alpha2A-adrenoceptors may represent an effective treatment strategy for mood disorders and visceral pain. BRL-44408 increases hippocampal noradrenalin release following systemic administration. BRL-44408 has potential therapeutic application in the treatment of extrapyramidal side effects produced by some antipsychotic medications.

CNS Activity

Curator's Comment: In rats, BRL-44408 penetrated the central nervous system resulting in peak brain and plasma concentrations of 586 ng/g and 1124 ng/ml, respectively. In the forced swim test and schedule-induced polydipsia assay, BRL-44408 produced an antidepressant-like response by dose-dependently decreasing immobility time and adjunctive water intake, respectively, while in a model of visceral pain, BRL-44408 exhibited analgesic activity by decreasing para-phenylquinone (PPQ)-induced abdominal stretching.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Interaction of formamidine pesticides with the presynaptic alpha(2)-adrenoceptor regulating.
2001 May 1
Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
2003 Mar
Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders.
2009 Apr 24
Patents

Patents

Sample Use Guides

Rats: in the FST (forced swim test), acute treatment with BRL-44408 (3–30 mg/ kg i.p.) produced a significant decrease in immobility time relative to vehicle-treated animals. BRL-44408 at both 10 and 30 mg/kg significantly decreased immobility time by 30% and 49%, respectively. Acute pretreatment with BRL-44408 (1–30 mg/kg, i.p.) produced a dose-dependent reversal of PPQinduced stretching behaviour relative to vehicle. BRL-44408 at 10 and 30 mg/kg produced a significant blockade of PPQ-induced stretching by 32% and 52%, respectively.
Route of Administration: Intraperitoneal
In Vitro Use Guide
Curator's Comment: Subtype-selective antagonists were used to determine the subtype of alpha2-adrenoceptor controlling noradrenaline release in rat locus coeruleus. Noradrenaline release was measured in locus coeruleus slices using fast cyclic voltammetry at carbon fibre microelectrodes.
On long stimulation trains (40 pulses, 20 Hz), the alpha2A-adrenoceptor selective antagonist BRL-44408 at 100 nM and 1 uM significantly increased stimulated noradrenaline release.
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:12:03 GMT 2023
Edited
by admin
on Sat Dec 16 09:12:03 GMT 2023
Record UNII
96KFS04PNM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BRL-44408 MALEATE
Common Name English
BRL-44408 MALEATE SALT
Common Name English
1H-ISOINDOLE, 2-((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)METHYL)-2,3-DIHYDRO-1-METHYL-, (2Z)-2-BUTENEDIOATE (1:1)
Systematic Name English
2-(2H-(1-METHYL-1,3-DIHYDROISOINDOLE)METHYL)-4,5-DIHYDROIMIDAZOLE MALEATE SALT
Systematic Name English
Code System Code Type Description
FDA UNII
96KFS04PNM
Created by admin on Sat Dec 16 09:12:04 GMT 2023 , Edited by admin on Sat Dec 16 09:12:04 GMT 2023
PRIMARY
PUBCHEM
10382026
Created by admin on Sat Dec 16 09:12:04 GMT 2023 , Edited by admin on Sat Dec 16 09:12:04 GMT 2023
PRIMARY
CAS
681806-46-2
Created by admin on Sat Dec 16 09:12:04 GMT 2023 , Edited by admin on Sat Dec 16 09:12:04 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY